Nepra Foods resumes trading on the OTCQB after regulatory approval

On April 21, 2025, Nepra Foods Inc., a company that specializes in allergen and gluten-free food ingredient technologies, announced the approval of OTC Capital Markets for the resumption of trading on the OTCQB marketplace. This decision came into effect on April 17, 2025, signifying a pivotal moment for the company as it aims to provide ongoing transparency and timely disclosures to its investors. The company has expressed gratitude towards the personnel at both OTC Capital Markets and Odyssey Trust Company for facilitating this process, ensuring that corporate actions are undertaken efficiently. Furthermore, the CEO of Nepra Foods, Billy Hogan, emphasized the importance of maintaining open communication with shareholders, highlighting a commitment to deliver factual and complete information regarding the company's growth and developments. He encouraged shareholders to engage directly with the executive team, underscoring the company’s dedication to investor relations. The announcement also serves as a reminder of the challenging regulatory environment firms face, particularly those working in the food sector. Nepra Foods is strategically positioned to leverage its specialization in gluten-free and allergen-free technologies to attract a growing consumer base increasingly conscious of food allergens and dietary restrictions. The approval by OTC Capital Markets is expected to enhance the company’s visibility in the market and attract potential investors who are interested in this niche sector. As Nepra Foods moves forward, it will need to continue adapting to the evolving market landscape while providing transparent communication and prioritizing shareholder engagement. The company's future trajectory will depend on its ability to navigate these challenges effectively and capitalize on growth opportunities, especially as consumer preferences shift towards healthier and specialty food products.